{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:53:17Z","timestamp":1786985597837,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cancer Epidemiology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/j.canep.2019.101649","type":"journal-article","created":{"date-parts":[[2019,12,6]],"date-time":"2019-12-06T19:31:49Z","timestamp":1575660709000},"page":"101649","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"special_numbering":"C","title":["Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers"],"prefix":"10.1016","volume":"64","author":[{"given":"Maggie","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nosayaba","family":"Osazuwa-Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C.","family":"Simpson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Schootman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay F.","family":"Piccirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Warner K.","family":"Huh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Adjei Boakye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.canep.2019.101649_bib0005","first-page":"65","article-title":"Human papillomavirus\u2013associated cancers\u2014United States, 2008\u20132012","author":"Viens","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"S10","key":"10.1016\/j.canep.2019.101649_bib0010","doi-asserted-by":"crossref","first-page":"3036","DOI":"10.1002\/cncr.23764","article-title":"HPV prophylactic vaccines and the potential prevention of noncervical cancers in both men and women","volume":"113","author":"Gillison","year":"2008","journal-title":"Cancer"},{"issue":"2","key":"10.1016\/j.canep.2019.101649_bib0015","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.clindermatol.2013.08.007","article-title":"HPV-associated diseases","volume":"32","author":"Ljubojevic","year":"2014","journal-title":"Clin. Dermatol."},{"key":"10.1016\/j.canep.2019.101649_bib0020","series-title":"Cancer Facts & Figures 2017","author":"American Cancer Society","year":"2017"},{"issue":"2","key":"10.1016\/j.canep.2019.101649_bib0025","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/hed.23869","article-title":"Improved overall survival and mortality in head and neck cancer with adjuvant concurrent chemoradiotherapy in national databases","volume":"38","author":"Lin","year":"2016","journal-title":"Head Neck"},{"issue":"8","key":"10.1016\/j.canep.2019.101649_bib0030","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1001\/jamaoto.2018.0993","article-title":"Incidence and risk of second primary malignant neoplasm after a first head and neck squamous cell carcinoma","volume":"144","author":"Adjei Boakye","year":"2018","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"2","key":"10.1016\/j.canep.2019.101649_bib0035","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1001\/jamaoncol.2017.4478","article-title":"Primary cancer vs competing causes of death in survivors of head and neck cancer","volume":"4","author":"Simpson","year":"2018","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.101649_bib0040","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/ijc.32101","article-title":"Trends in the risk and burden of second primary malignancy among survivors of smoking-related cancers in the United States","volume":"145","author":"Adjei Boakye","year":"2019","journal-title":"Int. J. Cancer"},{"issue":"11","key":"10.1016\/j.canep.2019.101649_bib0045","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1001\/jamaoncol.2017.0465","article-title":"Second primary malignant neoplasms and survival in adolescent and young adult cancer survivors","volume":"3","author":"Keegan","year":"2017","journal-title":"JAMA Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.101649_bib0050","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/hed.20665","article-title":"Health behaviors of head and neck cancer patients the first year after diagnosis","volume":"30","author":"Duffy","year":"2008","journal-title":"Head Neck"},{"issue":"1","key":"10.1016\/j.canep.2019.101649_bib0055","first-page":"43","article-title":"Association between head and neck squamous cell carcinoma survival, smoking at diagnosis, and marital status","volume":"144","author":"Osazuwa-Peters","year":"2017","journal-title":"JAMA Otolaryngol. Head Neck Surg."},{"issue":"9","key":"10.1016\/j.canep.2019.101649_bib0060","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1111\/j.1349-7006.2010.01642.x","article-title":"Tobacco smoking and regression of low-grade cervical abnormalities","volume":"101","author":"Matsumoto","year":"2010","journal-title":"Cancer Sci."},{"issue":"14","key":"10.1016\/j.canep.2019.101649_bib0065","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1001\/jama.2014.13183","article-title":"Tobacco use and oral HPV-16 infection","volume":"312","author":"Fakhry","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/j.canep.2019.101649_bib0070","series-title":"Incidence - SEER 18 Regs Custom Data (with additional treatment fields), Nov 2016 Sub (2000-2014) <Katrina\/Rita Population Adjustment> - Linked To County Attributes - Total U.S., 1969-2015 Counties","author":"Surveillance","year":"2019"},{"key":"10.1016\/j.canep.2019.101649_bib0075","author":"National Cancer Institute","year":"2016"},{"issue":"11","key":"10.1016\/j.canep.2019.101649_bib0080","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1002\/1097-0142(19951201)76:11<2343::AID-CNCR2820761124>3.0.CO;2-#","article-title":"Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute","volume":"76","author":"Zippin","year":"1995","journal-title":"Cancer"},{"issue":"12","key":"10.1016\/j.canep.2019.101649_bib0085","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1200\/JCO.2003.94.023","article-title":"The surveillance, epidemiology, and end-results program database as a resource for conducting descriptive epidemiologic and clinical studies","volume":"21","author":"Harlan","year":"2003","journal-title":"J. Clin. Oncol."},{"issue":"26","key":"10.1016\/j.canep.2019.101649_bib0090","doi-asserted-by":"crossref","first-page":"661","DOI":"10.15585\/mmwr.mm6526a1","article-title":"Human papillomavirus-associated cancers - United States, 2008\u20132012","volume":"65","author":"Viens","year":"2016","journal-title":"MMWR Morb. Mortal. Wkly. Rep."},{"issue":"6","key":"10.1016\/j.canep.2019.101649_bib0095","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv086","article-title":"US assessment of HPV types in cancers: implications for current and 9-Valent HPV vaccines","volume":"107","author":"Saraiya","year":"2015","journal-title":"J. Natl. Cancer Inst."},{"issue":"10 Suppl","key":"10.1016\/j.canep.2019.101649_bib0100","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1002\/cncr.23758","article-title":"Using population-based cancer registry data to assess the burden of human papillomavirus-associated cancers in the United States: overview of methods","volume":"113","author":"Watson","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2019.101649_bib0105","series-title":"International Classification of Diseases for Oncology (ICD-O-3)","author":"Fritz","year":"2000"},{"issue":"95","key":"10.1016\/j.canep.2019.101649_bib0110","first-page":"64","article-title":"Cancer registration: principles and methods. Classification and coding of neoplasms","author":"Muir","year":"1991","journal-title":"IARC Sci. Publ."},{"key":"10.1016\/j.canep.2019.101649_bib0115","series-title":"New Malignancies among Cancer Survivors: SEER Cancer Registries, 1973-2000","author":"Curtis","year":"2019"},{"key":"10.1016\/j.canep.2019.101649_bib0120","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ypmed.2016.06.041","article-title":"Risk of second primary cancer after a first potentially-human papillomavirus-related cancer: a population-based study","volume":"90","author":"Neumann","year":"2016","journal-title":"Prev. Med."},{"issue":"8","key":"10.1016\/j.canep.2019.101649_bib0125","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1002\/lary.27634","article-title":"Risk and outcomes for second primary human papillomavirus-related and -unrelated head and neck malignancy","volume":"129","author":"Adjei Boakye","year":"2019","journal-title":"Laryngoscope"},{"issue":"82","key":"10.1016\/j.canep.2019.101649_bib0130","first-page":"1","article-title":"Statistical methods in cancer research. Volume II--the design and analysis of cohort studies","author":"Breslow","year":"1987","journal-title":"IARC Sci. Publ."},{"issue":"4 Suppl","key":"10.1016\/j.canep.2019.101649_bib0135","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1002\/1097-0142(197710)40:4+<1892::AID-CNCR2820400820>3.0.CO;2-H","article-title":"Statistical methods for studying multiple primary malignant neoplasms","volume":"40","author":"Schoenberg","year":"1977","journal-title":"Cancer"},{"issue":"6","key":"10.1016\/j.canep.2019.101649_bib0140","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/oxfordjournals.aje.a117689","article-title":"Methodology for evaluating the incidence of second primary cancers with application to smoking-related cancers from the Surveillance, Epidemiology, and End Results (SEER) program","volume":"142","author":"Begg","year":"1995","journal-title":"Am. J. Epidemiol."},{"issue":"5","key":"10.1016\/j.canep.2019.101649_bib0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.1999","article-title":"Trends in risks for second primary cancers associated with index human papillomavirus\u2013associated cancers","volume":"1","author":"Suk","year":"2018","journal-title":"JAMA Netw. Open"},{"issue":"7","key":"10.1016\/j.canep.2019.101649_bib0150","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1002\/cncr.22963","article-title":"Trends in head and neck cancer incidence in relation to smoking prevalence: an emerging epidemic of human papillomavirus-associated cancers?","volume":"110","author":"Sturgis","year":"2007","journal-title":"Cancer"},{"key":"10.1016\/j.canep.2019.101649_bib0155","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.oraloncology.2016.11.011","article-title":"The role of HPV on the risk of second primary neoplasia in patients with oropharyngeal carcinoma","volume":"64","author":"Martel","year":"2017","journal-title":"Oral Oncol."},{"issue":"1","key":"10.1016\/j.canep.2019.101649_bib0160","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.radonc.2008.12.016","article-title":"Can we reduce the incidence of second primary malignancies occurring after radiotherapy? A critical review","volume":"91","author":"Tubiana","year":"2009","journal-title":"Radiother. Oncol."},{"issue":"7","key":"10.1016\/j.canep.2019.101649_bib0165","first-page":"4131","article-title":"Second primary malignancy in anal carcinoma--a US population-based study","volume":"35","author":"Shah","year":"2015","journal-title":"Anticancer Res."},{"issue":"43","key":"10.1016\/j.canep.2019.101649_bib0170","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001803","article-title":"Secondary primary malignancy risk in patients with cervical cancer in Taiwan: a nationwide population-based study","volume":"94","author":"Teng","year":"2015","journal-title":"Medicine"},{"issue":"21","key":"10.1016\/j.canep.2019.101649_bib0175","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1093\/jnci\/djm201","article-title":"Second cancers among 104,760 survivors of cervical cancer: evaluation of long-term risk","volume":"99","author":"Chaturvedi","year":"2007","journal-title":"J. Natl. Cancer Inst."},{"issue":"5","key":"10.1016\/j.canep.2019.101649_bib0180","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1093\/oxfordjournals.aje.a112399","article-title":"Correlations of incidence rates for selected cancers in the nine areas of the Third National Cancer survey","volume":"105","author":"Winkelstein","year":"1977","journal-title":"Am. J. Epidemiol."},{"issue":"12","key":"10.1016\/j.canep.2019.101649_bib0185","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/jnci\/89.12.868","article-title":"Identification of tobacco-specific carcinogen in the cervical mucus of smokers and nonsmokers","volume":"89","author":"Prokopczyk","year":"1997","journal-title":"J. Natl. Cancer Inst."},{"issue":"2","key":"10.1016\/j.canep.2019.101649_bib0190","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1128\/JVI.01813-07","article-title":"The cigarette smoke carcinogen benzo[a]pyrene enhances human papillomavirus synthesis","volume":"82","author":"Alam","year":"2008","journal-title":"J. Virol."},{"issue":"8","key":"10.1016\/j.canep.2019.101649_bib0195","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S1470-2045(10)70017-6","article-title":"HPV-associated head and neck cancer: a virus-related cancer epidemic","volume":"11","author":"Marur","year":"2010","journal-title":"Lancet Oncol."},{"issue":"2","key":"10.1016\/j.canep.2019.101649_bib0200","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1002\/hed.24100","article-title":"AHNS Series--do you know your guidelines? Guideline recommended follow-up and surveillance of head and neck cancer survivors","volume":"38","author":"Roman","year":"2016","journal-title":"Head Neck"},{"issue":"suppl_7","key":"10.1016\/j.canep.2019.101649_bib0205","first-page":"vii27","article-title":"Cervical cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"23","author":"Rollo","year":"2012","journal-title":"Ann. Oncol."},{"issue":"6","key":"10.1016\/j.canep.2019.101649_bib0210","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1016\/j.ajog.2011.03.008","article-title":"Posttreatment surveillance and diagnosis of recurrence in women with gynecologic malignancies: society of Gynecologic Oncologists recommendations","volume":"204","author":"Salani","year":"2011","journal-title":"Am. J. Obstet. Gynecol."},{"key":"10.1016\/j.canep.2019.101649_bib0215","doi-asserted-by":"crossref","DOI":"10.1093\/annonc\/mdu159","article-title":"Anal cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","author":"Glynne-Jones","year":"2014","journal-title":"Ann. Oncol."},{"issue":"suppl._6","key":"10.1016\/j.canep.2019.101649_bib0220","doi-asserted-by":"crossref","first-page":"vi115","DOI":"10.1093\/annonc\/mdt286","article-title":"Penile cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Van Poppel","year":"2013","journal-title":"Ann. Oncol."}],"container-title":["Cancer Epidemiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782119301596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1877782119301596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T05:25:35Z","timestamp":1761801935000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1877782119301596"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2]]},"references-count":44,"alternative-id":["S1877782119301596"],"URL":"https:\/\/doi.org\/10.1016\/j.canep.2019.101649","relation":{},"ISSN":["1877-7821"],"issn-type":[{"value":"1877-7821","type":"print"}],"subject":[],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of subsequent malignant neoplasms after an index potentially-human papillomavirus (HPV)-associated cancers","name":"articletitle","label":"Article Title"},{"value":"Cancer Epidemiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.canep.2019.101649","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101649"}}